Pharma Marketing Network
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

The Pharma Marketing Glossary
Click on a letter below to view a list of terms beginning with that letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Adverse Event (AE)

Similar or Alternative Terms Meaning the Same Thing Adverse Drug Event (ADE), Adverse Drug Reaction (ADR)
Related Term(s) Adverse Event Report (AER)

Definition

The definition of "adverse event" for both prescription drugs and dietary supplements is "any health-related event associated with the use of a that is adverse". This could include any unfavorable and unintended sign including an abnormal laboratory finding, symptom or disease, and, more seriously, death.

FDA defines an Adverse drug experience as "Any adverse event associated with the use of a drug in humans, whether or not considered drug related, including the following: An adverse event occurring in the course of the use of a drug product in professional practice; an adverse event occurring from drug overdose whether accidental or intentional; an adverse event occurring from drug abuse; an adverse event occurring from drug withdrawal; and any failure of expected pharmacological action."

FDA's MedWatch Form, which is used by physicians and consumers to report adverse events, includes the following outcomes attributed to adverse events:

  • Death
  • Life-threatening
  • Hospitalization
  • Disability or permanent damage
  • Congenital abnormality
  • Required intervention to prevent permanent impairment or damage

The FDA requires pharmaceutical companies to monitor and report all adverse events it learns about relating to its products. The agency expects "entities responsible for reporting will promptly review all adverse event information received or otherwise obtained, which potentially includes information from the Internet and social media tools."

Such events should be reported to FDA if there is knowledge of the four basic elements for submission of an individual case safety report, namely:

  1. An identifiable patient
  2. An identifiable reporter
  3. A suspect drug or biological product
  4. An adverse experience or fatal outcome suspected to be due to the suspect drug or biological product
FDA guidance states that those entities should review any Internet sites sponsored by them for adverse experience information, but are not responsible for reviewing any Internet sites that they do not sponsor; however, if they become aware of an adverse experience on an Internet site that they do not sponsor, they should review the adverse experience and determine if it should be reported to FDA.

Where to find more information:


Click on a letter below to view a list of terms beginning with that letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z



Messages from Our Sponsors

Pharma Marketing News | Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.